Ann Intern Med. 2003 Feb 18;138(4):360.
Food and Drug Administration approval of buprenorphine-naloxone for office treatment of addiction.
Resnick RB.
PMID: 12585846 [PubMed - indexed for MEDLINE]
Publication Types:
MeSH Terms:
Substances:
Full Text Sources:
Molecular Biology Databases: